title: [Branch retinal vein occlusion treated by intravitreal triamcinolone].
abstract: METHODS
  Five eyes with branch retinal vein occlusion (BRVO) were treated with intravitreal injection of 4 mg of triamcinolone. Four cases showed good visual acuity and macular thickness evolution after one dose. The remaining one case suffered a relapse three months later. Therefore a second injection was performed in that case.
  
  
  CONCLUSIONS
  Several treatments have been suggested to manage macular edema in BRVO. Intravitreal triamcinolone may be a therapeutic option to increase visual acuity and decrease macular thickness in patients with macular edema secondary to BRVO.
authors.affiliation: Departamento de Oftalmología, Clínica Universitaria de Navarra, Universidad de Navarra. asalinas@unav.es
authors.forename: A
authors.initials: A
authors.lastname: Salinas-Alamán
authors.forename: A
authors.initials: A
authors.lastname: García-Layana
authors.forename: L M
authors.initials: LM
authors.lastname: Sádaba-Echarri
authors.forename: A
authors.initials: A
authors.lastname: Belzunce-Manterola
mesh_terms: D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D007267:Injections; D008269:Macular Edema / Q000188:drug therapy / Q000209:etiology; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012170:Retinal Vein Occlusion / Q000150:complications / Q000188:drug therapy*; D013997:Time Factors; D041623:Tomography, Optical Coherence; D016896:Treatment Outcome; D014221:Triamcinolone / Q000008:administration & dosage*; D014792:Visual Acuity; D014822:Vitreous Body
chemical_list: D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D014221:Triamcinolone